1. Home
  2. THRM vs IOVA Comparison

THRM vs IOVA Comparison

Compare THRM & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$37.43

Market Cap

1.1B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.46

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
IOVA
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
968.6M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
THRM
IOVA
Price
$37.43
$2.46
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$39.00
$10.45
AVG Volume (30 Days)
179.4K
10.2M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$1,468,728,000.00
$250,425,000.00
Revenue This Year
$3.56
$60.94
Revenue Next Year
$2.52
$60.85
P/E Ratio
$37.73
N/A
Revenue Growth
N/A
175.62
52 Week Low
$22.75
$1.64
52 Week High
$41.09
$8.15

Technical Indicators

Market Signals
Indicator
THRM
IOVA
Relative Strength Index (RSI) 56.09 57.57
Support Level $36.70 $2.08
Resistance Level $38.06 $2.60
Average True Range (ATR) 1.13 0.13
MACD 0.07 0.02
Stochastic Oscillator 62.92 73.08

Price Performance

Historical Comparison
THRM
IOVA

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: